Pharmafile Logo

PharmiWeb

- PMLiVE

GSK signs agreement with Protas to streamline clinical trials

The new three-year agreement builds on an existing two-year relationship

- PMLiVE

US FDA approves Taiho’s Inqovi for older adults with acute myeloid leukaemia

In 2026, an estimated 22,720 people in the US will be diagnosed with AML

- PMLiVE

AstronauTx appoints Michelle Mellion as Chief Medical Officer

Deb Gouveia has also been appointed as Vice President, Clinical Operations and Development Strategy

- PMLiVE

Three Symposia, Three Years of Fellows, One Mission: Medscape Oncology at ASCO 2026

Three symposia. A third year of Fellows. AI live on the booth floor. Medscape Oncology arrives at ASCO 2026 (Booth #10099) with another ambitious oncology program.

Medscape Education

- PMLiVE

Lilly and UNICEF collaborate to improve non-communicable disease prevention

Six-year initiative to improve NCD prevention and care for children in low- and middle-income countries

- PMLiVE

Zeno appoints Cendrine Seror as Head of Health, Europe

Seror has more than 25 years’ experience in healthcare comms

- PMLiVE

Where Making Health Whole began

Mental health providers revealed years ago what healthcare is only now beginning to recognise: information alone does not sustain engagement. This article explores how Mednet’s heritage in mental health has...

Mednet

- PMLiVE

AbbVie Appoints Kelly Sanderson Schrems as UK VP and General Manager

Sanderson Schrems previously held senior US and global roles in her 13-year career at AbbVie

- PMLiVE

Boehringer and Immunitas agree on licensing deal for chronic inflammatory and autoimmune diseases

The agreement strengthens Boehringer Ingelheim’s growing immunology pipeline

- PMLiVE

How Sweet It Is: Medscape at ADA 2026

The energy is building as we prepare to head to New Orleans, LA, for the annual scientific sessions of the American Diabetes Association from June 4-8. The Medscape Diabetes and...

Medscape Education

- PMLiVE

Inizio launches Intelligent Congress: Turning medical event investment into measurable impact

Inizio, the global commercialization partner to the health and life sciences industry, today announced the launch of Intelligent Congress – a connected, end-to-end solution designed to help pharma organizations maximize...

Inizio

- PMLiVE

Novartis breaks ground on US radioligand therapy site

The construction is part of the company’s investment in US research and manufacturing

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links